tradingkey.logo

CapsoVision Inc

CV
5.050USD
+0.090+1.81%
交易中 美東報價延遲15分鐘
236.33M總市值
虧損本益比TTM

CapsoVision Inc

5.050
+0.090+1.81%

關於 CapsoVision Inc 公司

CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

CapsoVision Inc簡介

公司代碼CV
公司名稱CapsoVision Inc
上市日期Jul 02, 2025
CEOWang (Kang-Huai)
員工數量90
證券類型Ordinary Share
年結日Jul 02
公司地址18805 Cox Avenue
城市SARATOGA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編95070
電話14086241488
網址https://www.capsovision.com/
公司代碼CV
上市日期Jul 02, 2025
CEOWang (Kang-Huai)

CapsoVision Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Kang-Huai (Johnny) Wang
Mr. Kang-Huai (Johnny) Wang
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.10M
+1104004.00%
Mr. Chen Lung Tsai
Mr. Chen Lung Tsai
Independent Chairman of the Board
Independent Chairman of the Board
118.36K
+2887.00%
Mr. Wen-Herng Henry King
Mr. Wen-Herng Henry King
Independent Director Nominee
Independent Director Nominee
44.31K
+2887.00%
Ms. Hui Ying (Patty) Kuo
Ms. Hui Ying (Patty) Kuo
Independent Director
Independent Director
23.60K
+2887.00%
Ms. Julia S. Gouw
Ms. Julia S. Gouw
Independent Director Nominee
Independent Director Nominee
2.89K
+2887.00%
Mr. Douglas Atkinson
Mr. Douglas Atkinson
Head of Global Sales
Head of Global Sales
--
--
Dr. Joanne Imperial, M.D.
Dr. Joanne Imperial, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Min-Liang Chen
Mr. Min-Liang Chen
Director
Director
--
--
Mr. Eliyahou Harari
Mr. Eliyahou Harari
Director
Director
--
--
Mr. Howard Lee
Mr. Howard Lee
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Kang-Huai (Johnny) Wang
Mr. Kang-Huai (Johnny) Wang
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.10M
+1104004.00%
Mr. Chen Lung Tsai
Mr. Chen Lung Tsai
Independent Chairman of the Board
Independent Chairman of the Board
118.36K
+2887.00%
Mr. Wen-Herng Henry King
Mr. Wen-Herng Henry King
Independent Director Nominee
Independent Director Nominee
44.31K
+2887.00%
Ms. Hui Ying (Patty) Kuo
Ms. Hui Ying (Patty) Kuo
Independent Director
Independent Director
23.60K
+2887.00%
Ms. Julia S. Gouw
Ms. Julia S. Gouw
Independent Director Nominee
Independent Director Nominee
2.89K
+2887.00%
Mr. Douglas Atkinson
Mr. Douglas Atkinson
Head of Global Sales
Head of Global Sales
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
業務USD
名稱
營收
佔比
Products (capsules and capsule reading devices)
3.30M
93.39%
Services (cloud-based video delivery and reading services)
234.00K
6.61%
地區USD
名稱
營收
佔比
United States
2.75M
77.70%
Outside United States
789.00K
22.30%
業務
地區
業務USD
名稱
營收
佔比
Products (capsules and capsule reading devices)
3.30M
93.39%
Services (cloud-based video delivery and reading services)
234.00K
6.61%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Harari Eliyahou Et Al
9.19%
Ching-Hang (Shen)
8.52%
Kioxia Corporation
7.36%
CID Greater China Venture Capital Fund III, L.P.
6.67%
Shih-Chang (Stephen Wu)
5.04%
其他
63.22%
持股股東
持股股東
佔比
Harari Eliyahou Et Al
9.19%
Ching-Hang (Shen)
8.52%
Kioxia Corporation
7.36%
CID Greater China Venture Capital Fund III, L.P.
6.67%
Shih-Chang (Stephen Wu)
5.04%
其他
63.22%
股東類型
持股股東
佔比
Individual Investor
17.61%
Corporation
14.03%
Other Insider Investor
9.19%
Investment Advisor
0.51%
Investment Advisor/Hedge Fund
0.42%
Hedge Fund
0.06%
Research Firm
0.02%
Pension Fund
0.02%
Bank and Trust
0.01%
其他
58.14%

機構持股

更新時間: 1月21日 週三
更新時間: 1月21日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
37
408.58K
0.06%
--
2025Q4
39
481.38K
1.03%
+382.86K
2025Q3
11
196.14K
0.42%
+171.24K

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Harari Eliyahou Et Al
4.31M
9.19%
+4.31M
--
Jul 02, 2025
Ching-Hang (Shen)
3.99M
8.52%
+81.00K
+2.07%
Oct 01, 2025
Kioxia Corporation
3.45M
7.36%
+3.45M
--
Jul 02, 2025
CID Greater China Venture Capital Fund III, L.P.
3.13M
6.67%
-1.00
-0.00%
Sep 30, 2025
Shih-Chang (Stephen Wu)
2.36M
5.04%
+2.36M
--
Jul 02, 2025
Wang (Kang-Huai)
1.10M
2.36%
+1.10M
--
Jul 03, 2025
Harari (Michele)
576.80K
1.23%
+2.89K
+0.50%
Dec 31, 2025
The Vanguard Group, Inc.
69.58K
0.15%
+69.58K
--
Sep 30, 2025
Tsai (Chen Lung)
118.34K
0.25%
+2.89K
+2.50%
Dec 31, 2025
Geode Capital Management, L.L.C.
115.03K
0.25%
+90.13K
+361.98%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Proshares Ultra Russell 2000
佔比0%
ProShares Hedge Replication ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI